Evidence map›Paper›PMID 24028752›Full record

ArticleContraception2013

Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA.

Roxanne Jamshidi, Ana Penman-Aguilar, Jeffrey Wiener, Maria F Gallo, Jonathan M Zenilman, J H Melendez, Margaret Snead, Carolyn M Black, Denise J Jamieson, Maurizio Macaluso

Open access · greenAbstract read
In one paragraph

Article in Contraception, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.American journal of reproductive immunology (New York, N.Y. : 1989) · 2021
    Review
  8. Article
  9. Article
  10. PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation.Journal of acquired immune deficiency syndromes (1999) · 2019
    Observational
  11. Article
  12. Observational
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Roxanne JamshidiDepartment of Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Ana Penman-Aguilar
Jeffrey Wiener
Maria F Gallo
Jonathan M Zenilman
J H Melendez
Margaret Snead
Carolyn M Black
Denise J Jamieson
Maurizio Macaluso
Centers for Disease Control and Prevention · USJohns Hopkins Medicine · USCincinnati Children's Hospital Medical Center · USJohns Hopkins University · USNational Center for Chronic Disease Prevention and Health Promotion · USNational Center for Emerging and Zoonotic Infectious Diseases · USOffice of Minority Health and Health Equity · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundAlthough biological markers of women's exposure to semen from vaginal intercourse have been developed as surrogates for risk of infection or probability of pregnancy, data on their persistence time and clearance are limited. STUDY

designDuring 2006-2008, 52 couples were enrolled for three 14-day cycles of abstinence from vaginal sex during which women were exposed in the clinic to a specific quantity (10, 100 or 1000 μL) of their partner's semen. Vaginal swabs were collected before and at 1, 6, 12, 24, 48, 72 and 144 h after exposure for testing for prostate-specific antigen (PSA) and Y-chromosome DNA (Yc DNA).

resultsImmediately after exposure to 1000 μL of semen, the predicted sensitivity of being PSA positive was 0.96; this decreased to 0.65, 0.44, 0.21 and 0.07 at 6, 12, 24 and 48 h, respectively. Corresponding predicted sensitivity of being Yc DNA positive was 0.72 immediately postexposure; this increased to 0.76 at 1 h postexposure and then decreased to 0.60 (at 6 h), 0.63 (at 12 h), 0.49 (at 24 h), 0.21 (at 48 h), 0.17 (at 72 h) and 0.12 (at 144 h).

conclusionsOverall findings suggest that PSA may be more consistent as a marker of very recent exposure and that Yc DNA is more likely to be detected in the vagina after 12 h postexposure compared to PSA.

Indexed as

Chromosomes, Human, YAdultBiomarkersCoitusDNAFemaleHumansMaleProstate-Specific AntigenSemenVaginaVaginal SmearsBiomarkersDNAProstate-Specific AntigenClearanceProstate-specific antigenSemen biomarkersY-chromosome DNA

Identifiers

PMID24028752
PMCPMC5845849
OpenAlexW2054239777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.